Dr. Alex De Jesus
Claim this profileAccurate Clinical Research, Inc.
Studies Arthritis
Studies Rheumatoid Arthritis
6 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Alex De Jesus is currently running
Baricitinib
for Rheumatoid Arthritis
This trial compares the safety of two treatments for rheumatoid arthritis, focusing on the risk of blood clots. One treatment is baricitinib, an oral medication used for moderate to severe cases.
Recruiting3 awards Phase 43 criteria
Tildrakizumab
for Psoriatic Arthritis
This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of tildrakizumab in Subjects with Active Psoriatic Arthritis I (INSPIRE 1)
Recruiting1 award Phase 34 criteria
More about Alex De Jesus
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Alex De Jesus has experience with
- Baricitinib
- Tildrakizumab
- TNF Inhibitor
- Olokizumab
- GSK3196165 (Otilimab)
- Tofacitinib
Breakdown of trials Alex De Jesus has run
Arthritis
- Baricitinib for Rheumatoid Arthritis
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
- Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Rheumatoid Arthritis
- Baricitinib for Rheumatoid Arthritis
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
- Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Psoriatic Arthritis
Systemic Lupus Erythematosus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alex De Jesus specialize in?
Alex De Jesus focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Alex De Jesus currently recruiting for clinical trials?
Yes, Alex De Jesus is currently recruiting for 2 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Alex De Jesus has studied deeply?
Yes, Alex De Jesus has studied treatments such as Baricitinib, Tildrakizumab, TNF Inhibitor.
What is the best way to schedule an appointment with Alex De Jesus?
Apply for one of the trials that Alex De Jesus is conducting.
What is the office address of Alex De Jesus?
The office of Alex De Jesus is located at: Accurate Clinical Research, Inc., San Antonio, Texas 78229 United States. This is the address for their practice at the Accurate Clinical Research, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.